Neurocrine’s mixed schizophrenia data disappoint Wall Street biopharmadive.com/news/neurocrin… $NBIX by Jacob Bell

J&J submits touted autoimmune disease drug for FDA approval biopharmadive.com/news/johnson-j… $JNJ by Kristin Jensen

Keytruda fails lung and skin cancer trials, limiting further expansion biopharmadive.com/news/merck-key… $MRK Jon Gardner

BioMarin to lay off over 200 employees biopharmadive.com/news/biomarin-… $BMRN by Delilah Alvarado

Cell and gene therapy investment, once booming, is now in a slump biopharmadive.com/news/cell-gene… by Gwendolyn Wu

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices biopharmadive.com/news/alnylam-h… $ALNY by Ben Fidler

News Roundup: Novo builds heart failure case for semaglutide; Ventyx CFO departs biopharmadive.com/news/novo-sema…

Sanofi finds a silver lining in mixed MS drug results biopharmadive.com/news/sanofi-to… $SNY by Ben Fidler

AI specialist Recursion says lead drug is safe, but efficacy less clear biopharmadive.com/news/recursion… $RXRX by Ned Pagliarulo

Vaxcyte’s “best-case” data for pneumococcal vaccine boost shares biopharmadive.com/news/vaxcyte-s… $PCVX by Delilah Alvarado

New research could ease concerns over suicide risk of obesity drugs biopharmadive.com/news/jama-obes… $NVO $LLY Jon Gardner

A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology biopharmadive.com/news/cancer-im… $BMY $MRK Jon Gardner

Novartis builds out radiopharma production with expansion, new factory biopharmadive.com/news/novartis-… $NVS by Kristin Jensen

ArsenalBio raises $325M in one of the year’s largest biotech funding rounds biopharmadive.com/news/arsenalbi… by Gwendolyn Wu

News Roundup: High-dose Spinraza meets study goal; Top Dyne executives exit biopharmadive.com/news/high-dose…

BioMarin, having retrenched, outlines plans for growth biopharmadive.com/news/biomarin-… $BMRN by Delilah Alvarado

Lilly builds case for weekly insulin shot biopharmadive.com/news/lilly-wee… $LLY Jon Gardner

GSK antibody drug reduces COPD attacks in trial biopharmadive.com/news/gsk-nucal… $GSK by Kristin Jensen

Lykos CEO to depart after FDA rejection, layoffs biopharmadive.com/news/lykos-amy… by Ned Pagliarulo

News Roundup: Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise biopharmadive.com/news/obesity-d…